SEC FORM 3

Please wait

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gosk Kimberly Shannon

(Last)

(First)

(Middle)

1 CARRIER PLACE

(Street)

FARMINGTON

06032

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/01/2025

3. Issuer Name and Ticker or Trading Symbol
Otis Worldwide Corp [ OTIS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP & CPO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	5,688	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	⁽²⁾	⁽¹⁾	Common Stock	1,331	$0	D
Restricted Stock Units	⁽³⁾	⁽¹⁾	Common Stock	595	$0	D
Restricted Stock Units	⁽⁴⁾	⁽¹⁾	Common Stock	319	$0	D
Stock Appreciation Rights	⁽⁵⁾	02/05/2034	Common Stock	3,287	$91.94	D
Stock Appreciation Rights	⁽⁶⁾	02/06/2033	Common Stock	3,094	$83.63	D
Stock Appreciation Rights	⁽⁷⁾	02/02/2032	Common Stock	2,649	$81.85	D
Stock Appreciation Rights	⁽⁸⁾	02/04/2031	Common Stock	3,734	$63.93	D
Stock Appreciation Rights	⁽⁹⁾	02/03/2030	Common Stock	6,046	$80.97	D

Explanation of Responses:

1. Restricted Stock Units (RSUs) convert into common stock on a one-for-one basis and include the right to receive dividend equivalents that are credited as additional RSUs.

2. These RSUs are scheduled to vest in three substantially equal annual installments beginning on the first anniversary of the date of grant. The date of grant was February 4, 2025.

3. These RSUs are scheduled to vest in two substantially equal annual installments on the second and third anniversaries of the date of grant. The date of grant was February 6, 2024.

4. These RSUs are scheduled to vest on the third anniversary of the date of grant. The date of grant was February 7, 2023.

5. These Stock Appreciation Rights (SARs) were granted on February 6, 2024. 1,095 SARs became exercisable on the first anniversary of the date of grant and the remaining 2,192 SARs are scheduled to become exercisable in two substantially equal annual installments on the second and third anniversaries of the date of grant.

6. These SARs were granted on February 7, 2023. 2,062 SARs became exercisable on the first and second anniversaries of the date of grant. The remaining 1,032 SARs are scheduled to become exercisable on the third anniversary of the date of grant.

7. These SARs were granted on February 3, 2022 and became fully exercisable on the third anniversary of the date of grant.

8. These SARs were granted on February 5, 2021 and became fully exercisable on the third anniversary of the date of grant.

9. These SARs were granted on February 4, 2020 and became fully exercisable on the third anniversary of the date of grant.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	Toby Smith, Attorney-in-Fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.